Genetic medicines, like those based on CRISPR/Cas9, need a delivery method to reach their intended destination. One popular vector to accomplish this is hollowed-out adeno-associated viruses. By repurposing a biological structure that’s evolved to enter cells, it’s possible to introduce genetic medicine instead of viral material. However, these viral vectors can’t hold a very big payload, being restricted to about 4.7 kilobases.